CPHI Online Newsletter

Top Products

CPHI Pharmaceutical Products, Companies and News

News Eisai begins US FDA rolling submission for Alzheimer’s drug Leqembi

Japanese drugmaker Eisai, in partnership with Biogen, have announced that they have begun submitting data on a rolling basis to the US FDA for a marketing application of a subcutaneous injectable form of Alzheimer’s drug Leqembi. 

News Racial disparities in diagnosis and drug use for dementia symptoms

A study from the USC Schaeffer Center for Health Policy & Economics has revealed the existence of racial disparities in the US for the diagnosis of dementia and the use of drug treatments for symptoms. 

News MDMA-assisted therapy for PTSD to be reviewed by US FDA

American public benefit corporation (PBC) Lykos Therapeutics have announced that the US FDA Psychopharmacologic Drugs Advisory Committee (PDAC) will review data supporting their new drug application (NDA) for MDMA capsules, which are to be used in comb...

Pharmaceutical Industry Content

Pharmaceutical Industry Webinars

Sponsored Pharmaceutical Industry News

Sponsored Pharmaceutical Companies